Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

Published:2010-10 Issue:9747 Volume:376 Page:1164-1174
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Hallek M,Fischer K,Fingerle-Rowson G,Fink AM,Busch R,Mayer J,Hensel M,Hopfinger G,Hess G,von Grünhagen U,Bergmann M,Catalano J,Zinzani PL,Caligaris-Cappio F,Seymour JF,Berrebi A,Jäger U,Cazin B,Trneny M,Westermann A,Wendtner CM,Eichhorst BF,Staib P,Bühler A,Winkler D,Zenz T,Böttcher S,Ritgen M,Mendila M,Kneba M,Döhner H,Stilgenbauer S

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology;Dores;Br J Haematol,2007

2. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001;Morton;Blood,2006

3. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia;Binet;Blood,2006

4. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis;Binet;Cancer,1981

5. Clinical staging of chronic lymphocytic leukemia;Rai;Blood,1975

Cited by 1652 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia;Annals of Hematology;2024-02-03

2. JAK/STAT in leukemia: a clinical update;Molecular Cancer;2024-01-26

3. Targeted Therapies in Cancer Treatment: Unveiling the Latest Breakthroughs and Promising Approaches;Journal for Research in Applied Sciences and Biotechnology;2024-01-10

4. A Review of Anti-CD20 Antibodies in the Management of B-Cell Lymphomas;Lymphatics;2024-01-05

5. Maintenance therapy for chronic lymphocytic leukaemia;Cochrane Database of Systematic Reviews;2024-01-04